JP2004503525A5 - - Google Patents

Download PDF

Info

Publication number
JP2004503525A5
JP2004503525A5 JP2002510429A JP2002510429A JP2004503525A5 JP 2004503525 A5 JP2004503525 A5 JP 2004503525A5 JP 2002510429 A JP2002510429 A JP 2002510429A JP 2002510429 A JP2002510429 A JP 2002510429A JP 2004503525 A5 JP2004503525 A5 JP 2004503525A5
Authority
JP
Japan
Prior art keywords
chem
trans
chiral
cispentacin
pharm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002510429A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004503525A (ja
JP3872427B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2001/006541 external-priority patent/WO2001096285A1/en
Publication of JP2004503525A publication Critical patent/JP2004503525A/ja
Publication of JP2004503525A5 publication Critical patent/JP2004503525A5/ja
Application granted granted Critical
Publication of JP3872427B2 publication Critical patent/JP3872427B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002510429A 2000-06-14 2001-06-08 β−アミノ酸ニトリル誘導体 Expired - Fee Related JP3872427B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00112577 2000-06-14
PCT/EP2001/006541 WO2001096285A1 (en) 2000-06-14 2001-06-08 Beta-amino acid nitrile derivatives

Publications (3)

Publication Number Publication Date
JP2004503525A JP2004503525A (ja) 2004-02-05
JP2004503525A5 true JP2004503525A5 (enExample) 2005-02-03
JP3872427B2 JP3872427B2 (ja) 2007-01-24

Family

ID=8168969

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002510429A Expired - Fee Related JP3872427B2 (ja) 2000-06-14 2001-06-08 β−アミノ酸ニトリル誘導体

Country Status (28)

Country Link
US (1) US6462076B2 (enExample)
EP (1) EP1294679B1 (enExample)
JP (1) JP3872427B2 (enExample)
KR (1) KR20030029057A (enExample)
CN (1) CN1324006C (enExample)
AR (1) AR031594A1 (enExample)
AT (1) ATE304997T1 (enExample)
AU (2) AU6605601A (enExample)
BR (1) BR0111733A (enExample)
CA (1) CA2410303C (enExample)
DE (1) DE60113533T2 (enExample)
EC (1) ECSP024383A (enExample)
ES (1) ES2248346T3 (enExample)
HR (1) HRP20020963A2 (enExample)
HU (1) HUP0300896A3 (enExample)
IL (1) IL153166A0 (enExample)
JO (1) JO2234B1 (enExample)
MA (1) MA26913A1 (enExample)
MX (1) MXPA02012253A (enExample)
NO (1) NO20025823D0 (enExample)
NZ (1) NZ522587A (enExample)
PE (1) PE20020064A1 (enExample)
PL (1) PL359811A1 (enExample)
RU (1) RU2245871C2 (enExample)
UY (1) UY26769A1 (enExample)
WO (1) WO2001096285A1 (enExample)
YU (1) YU90802A (enExample)
ZA (1) ZA200209415B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9916575D0 (en) * 1999-07-15 1999-09-15 Cambridge Combinatorial Ltd Solid phase nitrile synthesis
ATE409482T1 (de) * 2001-03-02 2008-10-15 Merck Frosst Canada Ltd Cathepsincystein-proteasehemmer
CA2459364A1 (en) * 2001-09-13 2003-03-20 F. Hoffmann-La Roche Ag Ccr-3 receptor antagonists v
US6759428B2 (en) * 2001-12-04 2004-07-06 Roche Palo Alto Llc Indole nitriles
BR0214642A (pt) * 2001-12-04 2004-11-03 Hoffmann La Roche Compostos, métodos para a preparação de um composto, composições farmacêuticas que compreendem o mesmo e método para o tratamento e/ou prevenção de enfermidades que estão associadas com protéases de cisteìna e utilização desses compostos
US6995180B2 (en) * 2002-10-23 2006-02-07 Bristol Myers Squibb Company Glycinenitrile-based inhibitors of dipeptidyl peptidase IV and methods
AU2004242865A1 (en) * 2003-06-02 2004-12-09 F. Hoffmann-La Roche Ag Benzamide nitrile derivatives
WO2005000793A1 (ja) * 2003-06-26 2005-01-06 Taisho Pharmaceutical Co., Ltd. 2位置換シクロアルキルカルボン酸誘導体
WO2005000800A1 (en) * 2003-06-30 2005-01-06 Merck Frosst Canada Ltd. Cathepsin cysteine protease inhibitors
US20080125442A1 (en) * 2005-01-19 2008-05-29 Michael David Percival Cathepsin K Inhibitors and Atherosclerosis
EP1902031B1 (en) * 2005-07-06 2012-04-11 Merck Canada Inc. Cathepsin cysteine protease inhibitors
EP2240491B1 (en) 2008-01-09 2015-07-15 Amura Therapeutics Limited TETRAHYDROFURO(2,3-b)PYRROL-3-ONE DERIVATIVES AS INHIBITORS OF CYSTEINE PROTEINASES
US7893099B2 (en) * 2009-06-11 2011-02-22 Hoffman-La Roche Inc. Cyclopentane derivatives
CN105646362B (zh) 2011-07-26 2019-07-05 赛诺菲 3-杂芳酰基氨基-丙酸衍生物及其作为药物的用途
CN103086923B (zh) * 2013-01-21 2014-04-23 吉林大学 肼腈类组织蛋白酶k抑制剂及其在治疗骨质疏松症方面的应用
KR20160065854A (ko) * 2013-10-08 2016-06-09 머크 샤프 앤드 돔 코포레이션 카텝신 시스테인 프로테아제 억제제
NO2699580T3 (enExample) 2014-01-24 2018-02-24
CN105837479B (zh) * 2016-04-05 2017-10-27 吉林大学 肼腈类组织蛋白酶k抑制剂及其在制备治疗骨关节炎药物中的应用
KR102738945B1 (ko) 2018-03-01 2024-12-04 아스트라제네카 에이비이 (2s)-n-{(1s)-1-시아노-2-[4-(3-메틸-2-옥소-2,3-디하이드로-1,3-벤족사졸-5-일)페닐]에틸}-1,4-옥사제판-2-카복스아미드를 포함하는 약학 조성물
AU2019306532A1 (en) 2018-07-17 2021-03-04 Insmed Incorporated Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating Lupus Nephritis
CN113045491B (zh) * 2019-12-26 2024-09-06 罗欣药业(上海)有限公司 一种仑伐替尼及中间体的制备方法
CA3190610A1 (en) 2020-08-26 2022-03-03 Haisco Pharmaceuticals Pte. Ltd. Nitrile derivative that acts as inhibitor of dipeptidyl peptidase 1 and use thereof
JP2023551488A (ja) 2020-12-04 2023-12-08 瑞石生物医薬有限公司 カテプシンcの小分子阻害剤及びその医薬的使用
EP4538277A4 (en) 2022-06-07 2025-10-08 Reistone Biopharma Company Ltd PHARMACEUTICALLY ACCEPTABLE SALT OF A BENZO[C]CHROMANE COMPOUND, POLYMORPHIC FORM AND USE OF A PHARMACEUTICALLY ACCEPTABLE SALT
CA3258114A1 (en) 2022-06-07 2025-03-20 Reistone Biopharma Company Limited BENZO[C]CHROMANE COMPOUND POLYMORPH, ITS PREPARATION PROCESS AND ITS USE
CN120584108A (zh) 2023-01-06 2025-09-02 英斯梅德股份有限公司 新型可逆dpp1抑制剂及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU177576B (en) 1975-06-02 1981-11-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing 2-amino-cyclohexane carboxylic acid,its amides and similar compounds
HU185876B (en) * 1980-02-29 1985-04-28 Egyt Gyogyszervegyeszeti Gyar Composition for controlling growth of plants and process for producing the active agent
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
IT1283467B1 (it) 1996-07-19 1998-04-21 Menarini Farma Ind Derivati di cicloalcani 1,2 sostituiti come inibitori della trombina, procedimento per la loro preparazione e loro impiego in formulazioni
EP1024134A4 (en) * 1997-10-09 2003-05-14 Ono Pharmaceutical Co DERIVATIVES OF AMINOBUTANIC ACID
WO1999024460A2 (en) 1997-11-05 1999-05-20 Novartis Ag Dipeptide nitriles

Similar Documents

Publication Publication Date Title
JP2004503525A5 (enExample)
AU2002223640A1 (en) Fusion proteins as immunization treatments of alzheimer's disease
AU2003206413A1 (en) Substituted amino carboxamides for the treatment of alzheimer's disease
JP2002513761A5 (enExample)
ZA200507567B (en) Novel method for the synthesis of S-indoline-2 carboxylic acid and application thereof in the synthesis of perindopril
JP2001520991A5 (enExample)
TWD106805S1 (zh) 電視機(十六)
AU2003278370A1 (en) Improvements relating to the use of flasks in centrifugal evaporators
JPH10139702A5 (enExample)
JP2003171388A5 (enExample)
JP2002255902A5 (enExample)
TWM278428U (en) Air cushion for exercise
JP2004321729A (ja) ペットボトルによるスポーツ観戦等応援玩具
JP2005247809A5 (enExample)
TH18368S1 (th) "กะทะล้อถอดได้"
TH52753S (th) หัวไม้กอล์ฟ
TH76729S (th) เก้าอี้
TH25377S1 (th) เก้าอี้
TWD118854S1 (zh) 木質高爾夫球桿頭
TH29575S1 (th) "เตาอบไมโครเวฟ"
TH77337S (th) เตาอบไมโครเวฟ
TH29574S1 (th) เตาอบไมโครเวฟ
TH78243S (th) "เตาอบไมโครเวฟ"
TH98652S (th) ฝาจุกกาวน้ำ
TH28102S1 (th) ฝาจุกกาวน้ำ